一個新的白細胞膜抗原ZCH-2B8a編碼基因及其生物學特性的研究
發(fā)布時間：2018-09-12 06:43
【摘要】：血液系統(tǒng)惡性腫瘤是當今醫(yī)學上的頑癥之一,細胞膜表面分化抗原(CD)分子的研究能提高對其生物學行為的認識,有利于診斷治療。通過單克隆抗體(單抗)進而研究細胞膜抗原生物學特性是蛋白質(zhì)功能研究的重要方法。ZCH(Zhejiang Childrens Hospital)-288a(簡稱ZCH-288a)是本科研究室自行研制的鼠抗人造血細胞分化抗原的單抗,已經(jīng)提交第8屆國際人類白細胞分化抗原協(xié)作組會議(HLDA8)鑒定,根據(jù)HLDA8總部經(jīng)大量研究的反饋信息表明:該抗體識別的抗原性質(zhì)不明,屬國際上尚未認識的血細胞膜新的分化抗原(新的CD分子)。因此,對其識別抗原編碼基因克隆與測序及其生物學功能研究有著重要的科學意義和潛在的應(yīng)用前景。 1 直標鼠抗人新單抗ZCH-288a-FITC的研制及鑒定 為了深入研究ZCH-2B8a抗體識別抗原的表達譜及生物學功能,有利于利用流式細胞儀作多色分析和抗原阻滯試驗,減少實驗誤差,擬將該抗體研制成異硫氰酸熒光素(Fluorescein isothiocyanate,FITC)直接標記的抗體2B8a-FITC。在清潔級BALB/c小鼠腹腔內(nèi)注射1×10~6能分泌2BSa單抗(2B8aAb)的雜交瘤細胞,制備大量2B8aAb腹水。通過Econo-Pac蛋白A柱進行親和層析,純化2B8aAb,純化后的2B8aAb經(jīng)SDS-PAGE凝膠電泳檢測,純度高,達99%以上。采用改良Marsshall法,用FITC標記純化的2B8aAb,多余FITC經(jīng)PBS充分透析除去,用紫外分光光度計測定A495/A280比值為0.56,介于FITC熒光抗體的理想比值0.3～1.0之間。流式細胞術(shù)檢測顯示,直標單抗2B8a-FITC與間接標記法2B8a+GAM-FITC在Raji細胞上的反應(yīng)峰型相似,雖然前者的平均熒光強度指數(shù)(MFI,98.61)略低于后者(106.89),但陽性反應(yīng)率基本一致,分別為99.11%和99.00%,表明直標熒光抗體2B8a-FITC制備成功。
[Abstract]:Malignant tumor of blood system is one of the intractable diseases in modern medicine. The study of membrane surface differentiation antigen (CD) molecule can improve the understanding of its biological behavior and be helpful for diagnosis and treatment. It is an important method to study the biological characteristics of cell membrane antigen by monoclonal antibody (McAb). ZCH (Zhejiang Childrens Hospital) -288a (ZCH-288a) is a mouse monoclonal antibody against human hematopoietic cell differentiation antigen developed by our laboratory. It was submitted to the 8th International Conference on Human Leukocyte differentiation Antigen (HLDA8) for identification. According to the feedback from a large number of studies at HLDA8 headquarters, the antigenic nature of the antibody was unknown. It is a new differentiation antigen (new CD molecule) of blood cell membrane that has not been recognized in the world. therefore The cloning and sequencing of its antigen-coding gene and the study of its biological function have important scientific significance and potential application prospect. 1 the direct labeled mouse anti-human monoclonal antibody ZCH-288a-FITC In order to study the expression profile and biological function of ZCH-2B8a antibody recognition antigen, It is helpful to use flow cytometry for polychromatic analysis and antigen block test to reduce the experimental error. It is proposed to prepare the antibody 2B8a-FITC labeled directly by fluorescein isothiocyanate (Fluorescein isothiocyanate,FITC). A large number of 2B8aAb ascites were prepared by intraperitoneal injection of 1 脳 10 ~ (-6) 2BSa monoclonal antibody (2B8aAb) into the peritoneal cavity of clean BALB/c mice. 2B8aAbwas purified by affinity chromatography on Econo-Pac protein A column. The purified 2B8aAb was detected by SDS-PAGE gel electrophoresis and its purity was over 99%. The modified Marsshall method was used to label the purified 2B8aAbby FITC. The excess FITC was fully dialyzed by PBS. The ratio of A495/A280 determined by UV spectrophotometer was 0.56, and the ideal ratio of FITC fluorescent antibody was between 0.3n.0. The results of flow cytometry showed that the peak pattern of direct labeled monoclonal antibody (2B8a-FITC) on Raji cells was similar to that of indirect labeled 2B8a GAM-FITC. Although the average fluorescence intensity index (MFI,98.61) of the former was slightly lower than that of the latter (106.89), the positive reaction rate was basically the same. They were 99.11% and 99.00%, respectively, indicating that the 2B8a-FITC was successfully prepared.
【學位授予單位】：浙江大學
【學位級別】：博士
【學位授予年份】：2006
【分類號】：R392
本文編號：2238212
[Abstract]:Malignant tumor of blood system is one of the intractable diseases in modern medicine. The study of membrane surface differentiation antigen (CD) molecule can improve the understanding of its biological behavior and be helpful for diagnosis and treatment. It is an important method to study the biological characteristics of cell membrane antigen by monoclonal antibody (McAb). ZCH (Zhejiang Childrens Hospital) -288a (ZCH-288a) is a mouse monoclonal antibody against human hematopoietic cell differentiation antigen developed by our laboratory. It was submitted to the 8th International Conference on Human Leukocyte differentiation Antigen (HLDA8) for identification. According to the feedback from a large number of studies at HLDA8 headquarters, the antigenic nature of the antibody was unknown. It is a new differentiation antigen (new CD molecule) of blood cell membrane that has not been recognized in the world. therefore The cloning and sequencing of its antigen-coding gene and the study of its biological function have important scientific significance and potential application prospect. 1 the direct labeled mouse anti-human monoclonal antibody ZCH-288a-FITC In order to study the expression profile and biological function of ZCH-2B8a antibody recognition antigen, It is helpful to use flow cytometry for polychromatic analysis and antigen block test to reduce the experimental error. It is proposed to prepare the antibody 2B8a-FITC labeled directly by fluorescein isothiocyanate (Fluorescein isothiocyanate,FITC). A large number of 2B8aAb ascites were prepared by intraperitoneal injection of 1 脳 10 ~ (-6) 2BSa monoclonal antibody (2B8aAb) into the peritoneal cavity of clean BALB/c mice. 2B8aAbwas purified by affinity chromatography on Econo-Pac protein A column. The purified 2B8aAb was detected by SDS-PAGE gel electrophoresis and its purity was over 99%. The modified Marsshall method was used to label the purified 2B8aAbby FITC. The excess FITC was fully dialyzed by PBS. The ratio of A495/A280 determined by UV spectrophotometer was 0.56, and the ideal ratio of FITC fluorescent antibody was between 0.3n.0. The results of flow cytometry showed that the peak pattern of direct labeled monoclonal antibody (2B8a-FITC) on Raji cells was similar to that of indirect labeled 2B8a GAM-FITC. Although the average fluorescence intensity index (MFI,98.61) of the former was slightly lower than that of the latter (106.89), the positive reaction rate was basically the same. They were 99.11% and 99.00%, respectively, indicating that the 2B8a-FITC was successfully prepared.
【學位授予單位】：浙江大學
【學位級別】：博士
【學位授予年份】：2006
【分類號】：R392
【參考文獻】
相關(guān)期刊論文 前10條
1 萬澤生,王海濤,姜紹諄;人抗甲肝噬菌體抗體重鏈可變區(qū)基因的序列分析[J];第三軍醫(yī)大學學報;1997年05期
2 謝敏輝,傅承彬;噬菌體表面呈現(xiàn)技術(shù)及其在寄生蟲學中的應(yīng)用前景[J];國外醫(yī)學(寄生蟲病分冊);1999年02期
3 王長軍;噬菌體表面展示技術(shù)進展[J];國外醫(yī)學(免疫學分冊);2001年04期
4 侯佩強;噬菌體抗體庫技術(shù)及應(yīng)用研究進展[J];疾病控制雜志;2005年02期
5 鐘彥偉 ,成軍 ,王剛 ,洪源 ,王琳 ,李莉 ,張玲霞 ,陳菊梅;丙型肝炎病毒核心蛋白抗獨特型人源單鏈可變區(qū)抗體的篩選與鑒定[J];解放軍醫(yī)學雜志;2003年01期
6 王麗萍,厲廷有,武毅,李惟;在肽庫中篩選β_2糖蛋白I的小肽配體[J];吉林大學自然科學學報;2000年04期
7 王學,王海濤,陳萬榮;人抗 HBsAg 噬菌體抗體 Fab 段基因的序列分析及表達[J];軍事醫(yī)學科學院院刊;1997年01期
8 鐘彥偉;吳順華;成軍;徐東平;戴久增;高學松;曲建慧;王巧俠;李曉東;郭風勁;郭江;紀冬;;應(yīng)用噬菌體展示技術(shù)篩選干擾素β基因啟動子DNA結(jié)合蛋白的基因[J];免疫學雜志;2006年01期
9 張建瓊,謝維,張雪萍,林陵,單祥年,王琰;人源抗丙型肝炎病毒噬菌體抗體庫的構(gòu)建、篩選及表達[J];上海免疫學雜志;2000年05期
10 楊子義,董家新,王鑫,姚志建,沈倍奮;用噬菌體隨機肽庫確定抗TNF單抗識別的表位[J];生物化學與生物物理學報;1998年04期
，本文編號：2238212
本文鏈接：http://sikaile.net/yixuelunwen/binglixuelunwen/2238212.html
最近更新
教材專著
